Monocyte-platelet aggregates and CD11b expression as markers for thrombogenicity in atrial fibrillation

Christian Pfluecke1, Daniel Tarnowski2, Lina Plichta2

  • 1Technische Universität Dresden, Heart Center Dresden, University Hospital, Fetscherstrasse 76, 01307, Dresden, Germany. christian.pfluecke@mailbox.tu-dresden.de.

Abstract

Insights

Monocyte-platelet aggregates (MPAs) and CD11b expression are elevated in atrial fibrillation (AF) patients with left atrial thrombus. These biomarkers can help stratify thromboembolic risk in AF.

Area of Science:

  • Cardiology
  • Hematology
  • Immunology

Background:

  • Atrial fibrillation (AF) is linked to inflammation and thrombogenesis.
  • Monocyte-platelet aggregates (MPAs) indicate platelet and monocyte activation.
  • The association between MPAs and thrombogenicity in AF remains unclear.

Purpose of the Study:

  • To investigate differences in MPA content and CD11b expression in AF patients.
  • To determine the relationship between MPAs, CD11b expression, and atrial thrombus formation.

Main Methods:

  • 107 symptomatic AF patients underwent transesophageal echocardiography (TEE).
  • Flow cytometry quantified MPA content and CD11b expression on monocytes and granulocytes.
  • Analysis was performed on the day of TEE.

Main Results:

  • Patients with left atrial (LA) thrombus (n=27) had higher rates of age, diabetes, and heart failure compared to those without (n=80).
  • MPA content (p < 0.001) and CD11b expression on monocytes and granulocytes (p < 0.05) were significantly higher in patients with LA thrombus.
  • MPA content and CD11b expression were independent predictors of LA thrombus and negatively correlated with left atrial appendage flow velocity.

Conclusions:

  • Elevated MPA content and CD11b expression are associated with thrombus formation in AF patients.
  • These markers may serve as valuable biomarkers for assessing thromboembolic risk in AF.